Related Experiment Video
Updated: Apr 22, 2026

Synthesis and Characterization of 1,2-Dithiolane Modified Self-Assembling Peptides
Published on: August 20, 2018
Self-assembling choline mimicks with enhanced binding affinities to C-LytA protein
Yang Shi1, Hao Zhou1, Xiaoli Zhang1
1State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, and Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin 300071, P. R. China.
Researchers developed self-assembling peptides that target Streptococcus pneumoniae virulence. These novel choline mimics form nanoparticles and nanofibers, showing strong binding to key bacterial components, offering a promising strategy to combat pneumococcal infections.
Area of Science:
- Biochemistry
- Materials Science
- Microbiology
Background:
- Streptococcus pneumoniae causes significant human illnesses.
- Reducing pneumococcal virulence is crucial and requires effective inhibitors targeting choline-binding modules.
Purpose of the Study:
- To develop self-assembling choline mimics for multivalent architectures.
- To evaluate the binding affinity of these mimics to pneumococcal choline-binding modules.
Main Methods:
- Synthesis and characterization of two self-assembling peptides: Ada-GFFYKKK' (nanoparticles) and Nap-GFFYKKK' (nanofibers).
- Production of the C-terminal moiety of pneumococcal cell-wall amidase LytA (C-LytA).
- Assessment of binding interactions and association constants between the peptides and C-LytA.
Main Results:
- Successfully created self-assembling peptides yielding nanoparticle and nanofiber architectures.
- Demonstrated strong interactions between the self-assembling peptides and C-LytA.
- Observed significantly higher association constants for the peptides compared to individual units.
Conclusions:
- A novel self-assembly approach for creating potent pneumococcal virulence inhibitors.
- The developed multivalent architectures show promise for therapeutic applications against Streptococcus pneumoniae.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

